São Paulo, Brazil

Edecio Cunha Neto

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edecio Cunha Neto: Innovator in Anti-HIV Immunogens

Introduction

Edecio Cunha Neto is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of immunology, particularly in the development of anti-HIV immunogens. His work focuses on innovative methods for inducing immune responses against the HIV-1 virus.

Latest Patents

Edecio Cunha Neto holds a patent for "Anti-HIV immunogens and methods for inducing an immune response." This invention refers to new epitopes recognized by CD4+ T-lymphocytes. The patent outlines the uses of these epitopes and their combinations, particularly in the treatment or prevention of disorders caused by the HIV-1 virus. Additionally, it includes a composition comprising said epitopes and their applications in therapeutic and prophylactic vaccines against HIV-1. The invention also details methods for identifying epitopes and treating or preventing infections caused by the HIV-1 virus. He has 1 patent to his name.

Career Highlights

Throughout his career, Edecio Cunha Neto has worked with prominent institutions, including the Fundação de Amparo à Pesquisa do Estado de São Paulo and the Fundação Zerbini. His experience in these organizations has contributed to his expertise in immunology and vaccine development.

Collaborations

Edecio has collaborated with esteemed colleagues such as Jorge Elias Kalil Filho and Simone Gonçalves Da Fonseca. These partnerships have enhanced his research and innovation in the field of anti-HIV therapies.

Conclusion

Edecio Cunha Neto is a pioneering inventor whose work in anti-HIV immunogens has the potential to significantly impact the treatment and prevention of HIV-1 infections. His contributions to immunology are noteworthy and reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…